Product Information

SULFASALAZINE 500 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1985 per EA under NDC 00093323405. Its NADAC has been published 186 times since Apr 26, 2023.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SULFASALAZINE 500 MG TABLET

Sulfasalazine
$0.1985per EA

Strength

500 mg/1

NDC

00093323405

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

SULFASALAZINE

Approval Type

Generic (ANDA)

FDA Application

ANDA085828

FDA Approved

Before 1982

TE Code

AB

On Market Since

12/15/2022

Pharmacological Classes

Aminosalicylate
Aminosalicylic Acids

Price Statistics

The NADAC for SULFASALAZINE 500 MG TABLET has been published 186 times since Apr 26, 2023, and over the history we have for it it has risen 22.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1985 per EA
All-time high$0.2003 (Sep 16, 2026)
All-time low$0.1285 (Apr 17, 2024)
52-week high$0.2003
52-week low$0.1847
Median price$0.1793
Average price$0.1762
Largest weekly change+31.0% (Aug 21, 2024)
Weeks tracked186
Tracking sinceApr 26, 2023

Price History

1W

0.0%

1M

-0.3%

3M

-0.7%

6M

+0.7%

1Y

+9.0%

3Y

+18.7%

5Y

N/A

All

+22.6%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SULFASALAZINE 500 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SULFASALAZINE 500 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1985 per EA (NDC 00093323405), effective Nov 11, 2026.

How has the price of SULFASALAZINE 500 MG TABLET changed over time?

Over the history we have for it, the NADAC for SULFASALAZINE 500 MG TABLET has risen 22.6%. It has been tracked across 186 weekly CMS publications since Apr 26, 2023.

What are the highest and lowest recorded NADAC prices for SULFASALAZINE 500 MG TABLET?

Since Apr 26, 2023, the NADAC for SULFASALAZINE 500 MG TABLET has ranged from a low of $0.1285 (Apr 17, 2024) to a high of $0.2003 (Sep 16, 2026), with a median of $0.1793 per EA.

Are there cheaper alternatives to SULFASALAZINE 500 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SULFASALAZINE 500 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures SULFASALAZINE 500 MG TABLET?

SULFASALAZINE 500 MG TABLET (NDC 00093323405) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.